X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-01 | SEPN | Long Daniel D. | SVP, Drug Discovery | S - Sale+OE | $34.36 | -3,333 | 96,412 | -3% | -$114,528 | |||||
| D | 2026-06-22 | SEPN | Long Daniel D. | SVP, Drug Discovery | S - Sale+OE | $35.51 | -15,000 | 96,412 | -13% | -$532,582 | |||||
2025-11-10 | SEPN | Long Daniel D. | SVP, Drug Discovery | S - Sale | $18.06 | -3,501 | 92,911 | -4% | -$63,223 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |